Contemporary OB/GYN week in review: The Revi System, sleep health, and more

Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, March 10, 2025 - Friday, March 14, 2025), and click each link to read and watch anything you may have missed.

Revi System shows efficacy against urgency urinary incontinence

In a recent interview with Contemporary OB/GYN, John PFA Heesakkers, MD, PhD, MBA, with Maastricht Universitair Medisch Centrum, discussed the results of a study evaluating the efficacy of the Revi System, a neuromodulation-based treatment for urgency urinary incontinence.

The study, which has data from a 2-year period, included 150 participants and focused on the long-term effectiveness of the Revi System. Early in the study, a smaller cohort was used to examine the system's safety, and the results indicated that it was safe to use. While the initial aim was to assess safety, the secondary goal of evaluating efficacy showed promising results.

Heesakkers reported that after 2 years, 79% of participants experienced a reduction of more than 50% in urinary incontinence episodes, demonstrating the Revi System's effectiveness in addressing the condition. This long-term data is particularly notable as it suggests the system offers a durable solution to a common and often distressing medical issue.

Click here for the full video.

Sleep health linked to type 2 diabetes risk in women with gestational diabetes

The risk of type 2 diabetes (T2D) is increased among women with gestational diabetes (GD) sleeping less and snoring occasionally or regularly, according to a recent study published in JAMA Network Open.

There were 2891 women with GD history aged a mean 45.3 years included in the analysis, 19.5% of whom reported T2D during follow-up. Of participants, 92.7% were White while 7.3% were other race or ethnicity.

A significant association was reported between snoring and T2D, with a hazard ratio (HR) of 2.17 for occasional snoring and 2.66 for regular snoring when compared to never snoring after adjusting for covariates. When further adjusting for BMI, these HRs were 1.54 and 1.61, respectively.

Click here for the full article.

Study reveals low but rising cervical cancer risk after screening exit

While risks of cervical cancer and cervical cancer mortality are low among US women fulfilling the criteria to exit screening with contesting, these risks increase with age and the time since exiting, according to a recent study published in JAMA Network Open.

Similar 3-year risks were reported across the 4 models in scenario 1, ranging from 0.035% to 0.038%. While this exceeded the upper bound of the 95% confidence interval (CI) from Landy et al, the 5-year risks were within the 95% CI ranging from 0.075% to 0.083%.

In scenario 3, the 3-year risks also exceeded the 95% CI while 5-year risks fell within the 95% CI. Ranges were 0.032% to 0.048% and 0.076% to 0.092%, respectively. No link was reported between adhering to US screening guidelines and reduced CIN3 risks vs scenario 1. However, higher CIN3 risks were reported in scenario 3.

Click here for the full article.

Financial rewards for smoking cessation boost neonatal birth weight

Neonatal weight may be increased through offering financial rewards for smoking cessation during pregnancy, according to a recent study published in JAMA Network Open.

There were 12 studies included in the final analysis, reporting a combined relative risk of 2.43 for smoking cessation toward the end of pregnancy. One trial was excluded from complier average causal effects (CACE) analyses because of a negative estimated compliance rate.

In the trials reporting birth weight, a mean 46.30 g increase was reported among neonates born to women in the financial rewards group vs controls. The CACE analysis highlighted an increase of 206 g among neonates of women who stopped smoking because of financial incentives. This evidence was graded as moderate because of potential imprecision in the effect estimate.

Click here for the full article.

Robotic-assisted laparoscopy increases endometrial cancer survival rates

Robotic-assisted laparoscopy surgery (RALS) leads to a slight increase in survival benefit in endometrial cancer (EC) vs conventional laparoscopy surgery (CLS), according to a recent study published in the American Journal of Obstetrics & Gynecology.

Patients were stratified based on overweight status and age. The overall operating time was reported as the primary outcome, while secondary outcomes included short-term surgical complications, overall survival (OS), progression-free survival, and long-term surgical complications.

Improved OS was reported in the RALS group vs the CLS group, and this improvement remained when only evaluating stage 1 and stage 2 patients. Death was reported in 23.7% of patients overall, 32.7% in the CLS group, and 14.6% of the RALS group.

Click here for the full article.